how successful is mix&go, page-14

Interesting post biotech

Thanks Eddie for the clarification

"I was looking at ADO being more than just a speculative stock"

Unfortunately until ADO becomes cash flow positive without government assistance it is still a speculative rather than a growth or value stock.

I know it is frustrating and I share your frustration

The company maker deals, provided they have a decent royalty rate, will be the POC I and Alere deals, as they will have enough volume of sales to consistently bring in the receipts.

I guess we then look for the snowball and catchup effects that those who are resistant to change, will then make.

It's all a calculated risk although it is pleasing to hear validation from alere and posters like biotech.